The first preclinical therapy of Cabp2‐associated hearing impairment used AAV2/1 and AAV‐PHP.eB vectors to deliver Cabp2 coding sequence into the cochleae of P5‐7 Cabp2−/− mice [15]. This evidence concerns the gene CABP2 and Hearing impairment.